Why RFK Jr is doubling down on TrumpRx math that doesn't add up

Why RFK Jr is doubling down on TrumpRx math that doesn't add up

Donald Trump recently stood before a crowd and promised to cut drug prices by 500%. If you've taken a basic math class, you know that’s impossible. A 100% discount means the product is free. A 500% discount means the pharmacy would have to pay you several hundred dollars just to take the bottle home. It's a blatant statistical error, yet Robert F. Kennedy Jr., now leading the Department of Health and Human Services (HHS), is out here defending it like it’s gospel.

The disconnect isn't just about bad arithmetic. It’s about the launch of TrumpRx, the administration's new platform designed to bypass traditional insurance and offer "the lowest prices in the world." Kennedy isn't just ignoring the math; he’s reframing the entire conversation around a "historic miracle" that critics say is little more than a collection of coupons you could already find on your phone. Meanwhile, you can find related stories here: The British Waiting List Industry and the Death of the Safety Net.

The weird math of TrumpRx

During his recent testimony before the House Ways and Means Committee, Kennedy was pressed on the President's claims. Trump had specifically pointed to the weight-loss drug Wegovy, claiming he slashed the price from $1,300 to $199—a "578% difference."

Let's look at the actual numbers. Dropping a price from $1,300 to $200 is an 85% reduction. That’s a massive, life-changing cut for patients, but it’s not 578%. In the world of politics, 85% apparently doesn't sound "huge" enough. Kennedy’s defense? He’s shifting the focus away from the percentage and onto the "bold leadership" required to get pharmaceutical CEOs to the table at all. To explore the full picture, check out the excellent report by National Institutes of Health.

It's a classic distraction. By focusing on the "miracle" of the deal, he’s asking the public to ignore that the administration is using "alternative math" to sell its successes. Honestly, when the Secretary of Health refuses to acknowledge that you can't have a discount larger than 100%, it makes you wonder what else is being miscalculated in the federal budget.

Is TrumpRx actually saving you money?

The bigger issue isn't the President’s inability to use a calculator. It’s whether the platform actually works. A report from Energy and Commerce Committee Democrats recently tore into the site, finding that TrumpRx often lists prices higher than what you’d pay at a local Costco or through existing apps like GoodRx.

Senator Elizabeth Warren hammered this point home during a hearing, noting that the heartburn medication Protonix costs $200 on TrumpRx. The price at Costco? About $16. Kennedy’s response was that the administration is focusing on brand-name drugs, not generics.

"You're comparing apples to oranges because you're comparing the brand drug to the generic drug," Kennedy told the committee.

But for the average American, that distinction doesn't matter. If you're struggling to pay for your meds, you don't care if the "negotiated brand-name price" is a historic achievement if the generic version is still 90% cheaper at the pharmacy next door. By steering patients toward these "discounted" brand names, the platform might actually be tricking people into paying more than they have to.

The PBM problem and the "Most Favored Nation" dream

The administration's strategy relies on two main pillars:

  1. Cracking down on PBMs: Pharmacy Benefit Managers are the middlemen who negotiate deals between insurers and drugmakers. Trump has signed executive orders to force transparency on these "black box" players.
  2. Most Favored Nation (MFN) Pricing: This is the idea that the U.S. shouldn't pay a penny more for a drug than the lowest price paid by other wealthy nations.

It sounds great in a stump speech. In practice, it's a legal and logistical nightmare. Pharmaceutical companies have already started slamming these rules as "government overreach." They argue that if the U.S. forces these prices, the companies will simply stop investing in new research.

Kennedy is betting that his Make America Healthy Again (MAHA) movement can bully Big Pharma into submission. He’s pushing for a total reorganization of HHS to create a new agency—the Administration for a Healthy America (AHA). But while he talks about "ending the era of chronic disease," his agency is facing $16 billion in budget cuts. It's hard to build a healthcare revolution when you're selling off the tools.

What this means for your wallet right now

If you’re looking at TrumpRx hoping for a "500% discount," you’re going to be disappointed. But that doesn't mean there’s no value there. Here’s how you should actually handle your prescriptions in 2026:

  • Never trust one source: Check TrumpRx, but immediately compare it with GoodRx, Amazon Pharmacy, and the Costco member price.
  • Ask for the generic: If TrumpRx is pushing a brand-name "discount," ask your doctor if the generic is still cheaper. It almost always is.
  • Watch the PBM rules: If the administration actually succeeds in forcing PBMs to pass rebates directly to you at the counter, your out-of-pocket costs could drop significantly. But that's still tied up in court.

Don't get distracted by the flashy numbers or the political theater. Kennedy and Trump are trying to disrupt a system that has been broken for decades, but their "miracle" deals are currently built on shaky math and selective transparency. Your best bet is to stay skeptical and keep shopping around.

The "lowest prices in the world" might be coming, but for most people, they aren't on a government website yet.

DT

Diego Torres

With expertise spanning multiple beats, Diego Torres brings a multidisciplinary perspective to every story, enriching coverage with context and nuance.